J Pediatr Genet 2022; 11(03): 253-256
DOI: 10.1055/s-0040-1718536
Case Report

Retrospective Diagnosis of Pontocerebellar Hypoplasia Type 1B in a Family with Two Deceased Newborn Children

1   National Genetic Laboratory, University Hospital of Obstetrics and Gynecology “Maichin dom,” Medical University Sofia, Bulgaria
,
Silvia Andonova
1   National Genetic Laboratory, University Hospital of Obstetrics and Gynecology “Maichin dom,” Medical University Sofia, Bulgaria
,
Alexey Savov
1   National Genetic Laboratory, University Hospital of Obstetrics and Gynecology “Maichin dom,” Medical University Sofia, Bulgaria
› Author Affiliations

Abstract

Pontocerebellar hypoplasia type 1B is a severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. Pontocerebellar hypoplasia type 1B is caused by mutations in EXOSC3 gene. High prevalence of the p.Gly31Ala mutation was found recently, especially in the Roma ethnic minority. We present a young Bulgarian Roma family with two deceased newborn children manifesting severe neuromuscular disorder including severe muscle weakness, respiratory distress, and multiple joint contractures. Based on the clinical signs and family's population characteristics, DNA testing for the previously described EXOSC3 in Bulgarian Roma mutation c.92G > C; p.Gly31Ala was performed on blood samples of both parents and they were found to be heterozygous carriers. This finding indirectly confirmed the diagnosis of pontocerebellar hypoplasia type B in the deceased offspring. Knowledge of population-specific molecular bases of genetic conditions was the key to final diagnosis in the presented family. Designing of population-based clinical-genetic panels may be a powerful diagnostic tool for patients with such origin. Preconception carrier screening in high-risk population groups is a feasible option to discuss.



Publication History

Received: 07 August 2020

Accepted: 01 September 2020

Article published online:
08 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Appelhof B, Barth PG, Baas F. Classification of Pontocerebellar Hypoplasia: where does it end?. EMJ Neurol 2019; 7 (01) 52-61
  • 2 Norman RM. Cerebellar hypoplasia in Werdnig-Hoffmann disease. Arch Dis Child 1961; 36: 96-101
  • 3 Barth PG. Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev 1993; 15 (06) 411-422
  • 4 Namavar Y, Barth PG, Poll-The BT, Baas F. Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia. Orphanet J Rare Dis 2011; 6: 50
  • 5 van Dijk T, Baas F, Barth PG, Poll-The BT. What's new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet J Rare Dis 2018; 13 (01) 92
  • 6 OMIM. Accessed September 16, 2020 at: https://www.ncbi.nlm.nih.gov/omim
  • 7 Eggens VR, Barth PG, Niermeijer JM. et al. EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations. Orphanet J Rare Dis 2014; 9: 23
  • 8 Rudnik-Schöneborn S, Senderek J, Jen JC. et al. Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations. Neurology 2013; 80 (05) 438-446
  • 9 Wan J, Yourshaw M, Mamsa H. et al. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet 2012; 44 (06) 704-708
  • 10 Schwabova J, Brozkova DS, Petrak B. et al. Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma. J Neurogenet 2013; 27 (04) 163-169
  • 11 Ivanov I, Atkinson D, Litvinenko I. et al. Pontocerebellar hypoplasia type 1 for the neuropediatrician: genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature. Eur J Paediatr Neurol 2018; 22 (04) 674-681
  • 12 Kizilates SU, Talim B, Sel K, Köse G, Caglar M. Severe lethal spinal muscular atrophy variant with arthrogryposis. Pediatr Neurol 2005; 32 (03) 201-204
  • 13 Teoh HL, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M. Inherited paediatric motor neuron disorders: beyond spinal muscular atrophy. Neural Plast 2017; 2017: 6509493
  • 14 Chou SM, Gilbert EF, Chun RW. et al. Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA). Clin Neuropathol 1990; 9 (01) 21-32
  • 15 Namavar Y, Barth PG, Kasher PR. PCH Consortium. et al. Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia. Brain 2011; 134 (Pt 1): 143-156
  • 16 Szabó N, Szabó H, Hortobágyi T, Túri S, Sztriha L. Pontocerebellar hypoplasia type 1. Pediatr Neurol 2008; 39 (04) 286-288
  • 17 Rudnik-Schöneborn S, Sztriha L, Aithala GR. et al. Extended phenotype of pontocerebellar hypoplasia with infantile spinal muscular atrophy. Am J Med Genet A 2003; 117A (01) 10-17
  • 18 Rudnik-Schöneborn S, Wirth B, Röhrig D, Saule H, Zerres K. Exclusion of the gene locus for spinal muscular atrophy on chromosome 5q in a family with infantile olivopontocerebellar atrophy (OPCA) and anterior horn cell degeneration. Neuromuscul Disord 1995; 5 (01) 19-23
  • 19 Navarro C, Teijeira S. Neuromuscular disorders in the Gypsy ethnic group. A short review. Acta Myol 2003; 22 (01) 11-14
  • 20 Saugier-Veber P, Marguet F, Vezain M. et al. Pontocerebellar hypoplasia with rhombencephalosynapsis and microlissencephaly expands the spectrum of PCH type 1B. Eur J Med Genet 2020; 63 (04) 103814
  • 21 Pinto MM, Monges S, Malfatti E. et al. Sarcomeric disorganization and nemaline bodies in muscle biopsies of patients with EXOSC3-related type 1 pontocerebellar hypoplasia. Muscle Nerve 2019; 59 (01) 137-141